Recurrent Human Papillomavirus Type 16 Associated Cancer
1 clinical trials · Condition
◉ Watch Recurrent Human Papillomavirus Type 16 Associated Cancer
| Record | Firm | Date |
|---|---|---|
| TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers (NCT05132803) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-01 |
Track Recurrent Human Papillomavirus Type 16 Associated Cancer automatically
Every clearance here is in the API, with alerts when new ones post.